View in EDS HTML Full Text PDF Full Text

Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options.

Saved in:
Bibliographic Details
Title: Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options.
Authors: Easaw, Jacob C.1 (AUTHOR) jay.easaw@albertahealthservices.ca, Lim, Howard J.2 (AUTHOR), Karachiwala, Hatim3 (AUTHOR), Gill, Sharlene2,4 (AUTHOR), Zhu, Xiaofu1 (AUTHOR), Bateman, Justin4 (AUTHOR)
Source: Current Oncology. Nov2025, Vol. 32 Issue 11, p648. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189611431
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Easaw%2C+Jacob+C%2E%22">Easaw, Jacob C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jay.easaw@albertahealthservices.ca</i><br /><searchLink fieldCode="AR" term="%22Lim%2C+Howard+J%2E%22">Lim, Howard J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karachiwala%2C+Hatim%22">Karachiwala, Hatim</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gill%2C+Sharlene%22">Gill, Sharlene</searchLink><relatesTo>2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhu%2C+Xiaofu%22">Zhu, Xiaofu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bateman%2C+Justin%22">Bateman, Justin</searchLink><relatesTo>4</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Current+Oncology%22">Current Oncology</searchLink>. Nov2025, Vol. 32 Issue 11, p648. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189611431
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/curroncol32110648
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 648
    Titles:
      – TitleFull: Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Easaw, Jacob C.
      – PersonEntity:
          Name:
            NameFull: Lim, Howard J.
      – PersonEntity:
          Name:
            NameFull: Karachiwala, Hatim
      – PersonEntity:
          Name:
            NameFull: Gill, Sharlene
      – PersonEntity:
          Name:
            NameFull: Zhu, Xiaofu
      – PersonEntity:
          Name:
            NameFull: Bateman, Justin
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 11980052
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Current Oncology
              Type: main
ResultId 1